WHO ICTRP trial

CHRONDI

CTIS2024-513595-17-00 · EU Clinical Trials Information System · Not Recruiting

Key facts

Trial ID CTIS2024-513595-17-00
Public title CHRONDI
Scientific title Efficacy and tolerability of ODM-111 in chronic pain due to diabetic peripheral neuropathy - 3133004
Primary sponsor Orion Corporation
Registry EU Clinical Trials Information System
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries Australia;New Zealand;Bulgaria;Czechia;Germany;Hungary;Poland
Conditions CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY MedDRA version: 21.1Level: LLTClassification code: 10067547Term: Diabetic peripheral neuropathic pain Class: 10029205 MedDRA version: 20.1Level: LLTClassification code: 10049475Term…
Interventions Product Name: Para-Tabs 500 mg tabletti, Product Code:PRD593822, Pharmaceutical Form: TABLET, Other descriptive name: , Strength: , Product Name: ODM-111 Placebo, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A…
Registration date May 7, 2024
Target size 252
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations